Gabriele Bergers, PhD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Inter-regulatory function of immune-modulation and angiogenesis in cancer
    NIH R01CA201537Aug 1, 2016 - Jul 31, 2021
    Role: Principal Investigator
    Autophagy as a microenvironmental regulator of tumorigenesis and resistance
    NIH R01CA188404Sep 1, 2014 - Aug 31, 2020
    Role: Co-Principal Investigator
    Biophysical and molecular dialogue of glioma cells and the brain microenvironment
    NIH U54CA163155Sep 26, 2011 - Jul 31, 2016
    Role: Principal Investigator
    Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis
    NIH R01CA154383Apr 1, 2011 - Mar 31, 2016
    Role: Principal Investigator
    Perivascular Invasion of GBMs
    NIH R01CA113382Aug 15, 2006 - May 31, 2011
    Role: Principal Investigator
    PDGFRbeta+-Perivascular Cells In Tumor Angiogenesis
    NIH R01CA109390Aug 1, 2004 - Jul 31, 2009
    Role: Principal Investigator
    Mechanism and therapeutic targeting of evasive resistance to antiangiogenic drugs
    NIH R01CA099948Feb 11, 2003 - May 31, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021 03; 21(3):162-180. Bergers G, Fendt SM. PMID: 33462499.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    2. Tumors vs. Chronic Wounds: An Immune Cell's Perspective. Front Immunol. 2019; 10:2178. Hua Y, Bergers G. PMID: 31572387.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    3. Peptide-guided nanoparticles for glioblastoma targeting. J Control Release. 2019 08 28; 308:109-118. Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. PMID: 31255690.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    4. TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA. Neuro-Oncology. 2019 Apr 23; 21(Supplement_2):ii121-ii122. Wei Wang, Stefan Grossauer, Katharina Koeck, Erin Simonds, Edbert Lu, Gabriele Bergers, William Weiss, Claudia Petritsch. .
      View in: Publisher Site   Mentions:
    5. Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis. Annu Rev Physiol. 2019 02 10; 81:535-560. Mazzone M, Bergers G. PMID: 30742781.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    6. Where Have All the T Cells Gone? Immunity. 2018 10 16; 49(4):592-594. Vella G, Bergers G. PMID: 30332627.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    7. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nat Cell Biol. 2018 10; 20(10):1203-1214. Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, Obernier K, Alvarez-Buylla A, Bergers G, Phillips JJ, Nam DH, Bertozzi CR, Weaver VM. PMID: 30202050.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    8. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018 08; 21(3):425-532. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. PMID: 29766399.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansAnimals
    9. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. Semin Cancer Biol. 2018 10; 52(Pt 2):107-116. Missiaen R, Mazzone M, Bergers G. PMID: 29935312.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    10. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. J Pathol. 2018 06; 245(2):209-221. He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R. PMID: 29603739.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    11. ANGI-12. IDENTIFICATION OF A NOVEL TYROSINE KINASE/INTEGRIN COMPLEX THAT DRIVES BRAIN METASTASES. Neuro-Oncology. 2017 Nov 6; 19(suppl_6):vi24-vi24. Arman Jahangiri, Maxim Sidorov, Alan Nguyen, Garima Yagnik, Sung Won Han, Smita Mascharak, Michael De Lay, Jeffrey Wagner, Brandyn Castro, Brandon Imber, Kan Lu, Gabriele Bergers, William Weiss, Manish K Aghi. .
      View in: Publisher Site   Mentions:
    12. Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors. Oncotarget. 2017 Nov 21; 8(59):99207-99208. Allen E, Missiaen R, Bergers G. PMID: 29245888.
      View in: PubMed   Mentions: 1     Fields:    
    13. Cross-activating c-Met/ß1 integrin complex drives metastasis and invasive resistance in cancer. Proc Natl Acad Sci U S A. 2017 10 10; 114(41):E8685-E8694. Jahangiri A, Nguyen A, Chandra A, Sidorov MK, Yagnik G, Rick J, Han SW, Chen W, Flanigan PM, Schneidman-Duhovny D, Mascharak S, De Lay M, Imber B, Park CC, Matsumoto K, Lu K, Bergers G, Sali A, Weiss WA, Aghi MK. PMID: 28973887.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    14. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017 04 12; 9(385). Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. PMID: 28404866.
      View in: PubMed   Mentions: 139     Fields:    Translation:AnimalsCells
    15. Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations. Cold Spring Harb Symp Quant Biol. 2016; 81:21-29. Allen E, Missiaen R, Bergers G. PMID: 28396525.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    16. DRES-11. A CROSS-ACTIVATING c-Met/ß1 INTEGRIN COMPLEX DRIVES THERAPEUTIC RESISTANCE IN GLIOBLASTOMA. Neuro-Oncology. 2016 Nov 1; 18(suppl_6):vi53-vi54. Arman Jahangiri, Maxim Sidorov, Sung Won Han, William Chen, Jonathan Rick, Dina Schneidman-Duhovny, Smita Mascharak, Michael De Lay, Jeffrey Wagner, Brandyn Castro, Brandon Imber, Patrick Flanigan, Ruby Kuang, Kan Lu, Gabriele Bergers, Andrej Sali, William Weiss, Manish Aghi. .
      View in: Publisher Site   Mentions:
    17. Glioblastoma: Defining Tumor Niches. Trends Cancer. 2015 Dec; 1(4):252-265. Hambardzumyan D, Bergers G. PMID: 27088132.
      View in: PubMed   Mentions: 100     Fields:    
      View in: Publisher Site   Mentions:
    19. CANCER. Tumor angiogenesis, from foe to friend. Science. 2015 Aug 14; 349(6249):694-5. Rivera LB, Bergers G. PMID: 26273044.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    20. Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Rep. 2015 Apr 28; 11(4):577-91. Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G. PMID: 25892230.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    21. Intertwined regulation of angiogenesis and immunity by myeloid cells. Trends Immunol. 2015 Apr; 36(4):240-9. Rivera LB, Bergers G. PMID: 25770923.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    22. HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. NMR Biomed. 2014 Nov; 27(11):1361-70. Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM. PMID: 25199993.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    23. UNDERSTANDING AND TACKLING THE TUMOR-IMMUNE CELL DIALOGUE DURING PROGRESSION AND THERAPEUTIC RESISTANCE. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii16-iii16. Gabriele Bergers, Kan Lu, Lee Rivera. .
      View in: Publisher Site   Mentions:
    24. HIGH INTERSTITIAL FLUID PRESSURE REGULATES TUMOR GROWTH AND DRUG UPTAKE IN HUMAN GLIOBLASTOMA. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii32-iii32. Anders I. Persson, Shirin Ilkhanizadeh, Yekaterina A. Miroshnikova, Aaron Frantz, John N. Lakins, C. David James, Tracy R. McKnight, Mitchel S. Berger, Gabriele Bergers, William A. Weiss, Valerie M. Weaver. .
      View in: Publisher Site   Mentions:
    25. Angiogenesis. Targeting vascular sprouts. Science. 2014 Jun 27; 344(6191):1449-50. Rivera LB, Bergers G. PMID: 24970064.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    26. Novel target for peptide-based imaging and treatment of brain tumors. . 2014 Apr; 13(4):996-1007. Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P. PMID: 24493698.
      View in: PubMed   Mentions:
    27. Escape mechanisms from antiangiogenic therapy: an immune cell's perspective. Adv Exp Med Biol. 2014; 772:83-99. Rivera L, Pandika M, Bergers G. PMID: 24272355.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    28. Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity. Cancer Cell. 2013 Dec 09; 24(6):687-9. Rivera LB, Bergers G. PMID: 24332035.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    29. Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Clin Cancer Res. 2013 Apr 01; 19(7):1773-83. Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK. PMID: 23307858.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansAnimalsCells
    30. Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. CNS Oncol. 2013 Jan; 2(1):49-65. Lu KV, Bergers G. PMID: 23750318.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    31. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012 Jul 10; 22(1):21-35. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G. PMID: 22789536.
      View in: PubMed   Mentions: 243     Fields:    Translation:HumansCells
    32. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011 Sep 13; 20(3):328-40. Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, Weiss WA, Petritsch C. PMID: 21907924.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    33. Tumor microenvironment and progression. J Surg Oncol. 2011 May 01; 103(6):468-74. Dvorak HF, Weaver VM, Tlsty TD, Bergers G. PMID: 21480238.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    34. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010 Dec 14; 18(6):669-82. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA. PMID: 21156288.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    35. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 2009 Sep 01; 69(17):6889-98. Lu KV, Zhu S, Cvrljevic A, Huang TT, Sarkaria S, Ahkavan D, Dang J, Dinca EB, Plaisier SB, Oderberg I, Lee Y, Chen Z, Caldwell JS, Xie Y, Loo JA, Seligson D, Chakravari A, Lee FY, Weinmann R, Cloughesy TF, Nelson SF, Bergers G, Graeber T, Furnari FB, James CD, Cavenee WK, Johns TG, Mischel PS. PMID: 19690143.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    36. Identifying Mechanisms of Bevacizumab Evasion in Human Glioblastoma. Neurosurgery. 2009 Aug 1; 65(2):424. Manish Kumar Aghi, Samuel D. Rose, Scott R. VandenBerg, Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    37. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009 Mar 03; 15(3):220-31. Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O. PMID: 19249680.
      View in: PubMed   Mentions: 961     Fields:    Translation:HumansAnimals
    38. Bone Marrow-Derived Cells in GBM Neovascularization. CNS Cancer. 2009 Jan 1; 749-773. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    39. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008 Aug; 8(8):592-603. Bergers G, Hanahan D. PMID: 18650835.
      View in: PubMed   Mentions: 1118     Fields:    Translation:HumansCells
    40. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008 Jun 24; 6:14. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. PMID: 18577219.
      View in: PubMed   Mentions: 411     Fields:    Translation:HumansAnimalsCells
    41. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008 Jun; 10(3):254-64. Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. PMID: 18359864.
      View in: PubMed   Mentions: 49     Fields:    Translation:Animals
    42. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008 Mar; 13(3):206-20. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. PMID: 18328425.
      View in: PubMed   Mentions: 485     Fields:    Translation:AnimalsCells
    43. HIFa induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis. The FASEB Journal. 2008 Mar 1; 22:88.2-88.2. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    44. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008 Jan 29; 5(1):e19. Pietras K, Pahler J, Bergers G, Hanahan D. PMID: 18232728.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansAnimalsCells
    45. Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors. Methods Enzymol. 2008; 445:53-82. Lu K, Lamagna C, Bergers G. PMID: 19022055.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    46. Pericytes, the Mural Cells of the Microvascular System. Angiogenesis. 2008 Jan 1; 45-53. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    47. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res. 2007 Oct 01; 67(19):9435-42. Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. PMID: 17909053.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    48. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Res. 2006 Dec 01; 66(23):11331-40. Kawaguchi T, Yamashita Y, Kanamori M, Endersby R, Bankiewicz KS, Baker SJ, Bergers G, Pieper RO. PMID: 17145879.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    49. ID: 373 MMP-9-dependent regulation of angiogenesis and invasion in GBM. Journal of Thrombosis and Haemostasis. 2006 Oct 1; 4(s1):46-46. R. Du, C. Petritsch, H. Song, Z. Werb, G. Bergers. .
      View in: Publisher Site   Mentions:
    50. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol. 2006 Oct; 80(4):677-81. Lamagna C, Bergers G. PMID: 16888086.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    51. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents. Cancer Metastasis Rev. 2006 Jun; 25(2):243-52. Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M, Gordon MS. PMID: 16770536.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    52. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005 Oct; 8(4):299-309. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. PMID: 16226705.
      View in: PubMed   Mentions: 584     Fields:    Translation:HumansCells
    53. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005 Oct; 7(4):452-64. Bergers G, Song S. PMID: 16212810.
      View in: PubMed   Mentions: 466     Fields:    Translation:HumansAnimalsCells
    54. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005 Sep; 7(9):870-9. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G. PMID: 16113679.
      View in: PubMed   Mentions: 197     Fields:    Translation:AnimalsCells
    55. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 2005 Feb 01; 105(3):1094-101. Berger M, Bergers G, Arnold B, Hämmerling GJ, Ganss R. PMID: 15459006.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansAnimalsCells
    56. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res. 2004 Apr 15; 64(8):2751-8. Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO. PMID: 15087390.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    57. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 2003 Nov; 4(5):393-403. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D. PMID: 14667506.
      View in: PubMed   Mentions: 63     Fields:    Translation:AnimalsCells
    58. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 2003 Aug; 4(2):133-46. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS, Bergers G. PMID: 12957288.
      View in: PubMed   Mentions: 144     Fields:    Translation:AnimalsCells
    59. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003 Jun; 3(6):401-10. Bergers G, Benjamin LE. PMID: 12778130.
      View in: PubMed   Mentions: 980     Fields:    Translation:HumansAnimals
    60. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003 May; 111(9):1287-95. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. PMID: 12727920.
      View in: PubMed   Mentions: 410     Fields:    Translation:AnimalsCells
    61. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res. 2002 May 15; 62(10):2731-5. Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. PMID: 12019144.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    62. Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice. Cold Spring Harb Symp Quant Biol. 2002; 67:293-300. Bergers G, Hanahan D. PMID: 12858552.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    63. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000 Oct; 2(10):737-44. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. PMID: 11025665.
      View in: PubMed   Mentions: 808     Fields:    Translation:AnimalsCells
    64. Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects. Expert Opinion on Therapeutic Targets. 2000 Oct 1; 4(5):609-633. Mark D Sternlicht, Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    65. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest. 2000 Apr; 105(8):1045-7. Hanahan D, Bergers G, Bergsland E. PMID: 10772648.
      View in: PubMed   Mentions: 186     Fields:    Translation:HumansAnimalsCells
    66. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000 Feb; 10(1):120-7. Bergers G, Coussens LM. PMID: 10679388.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimals
    67. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999 Jun 01; 13(11):1382-97. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D. PMID: 10364156.
      View in: PubMed   Mentions: 272     Fields:    Translation:HumansAnimalsCells
    68. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999 Apr 30; 284(5415):808-12. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. PMID: 10221914.
      View in: PubMed   Mentions: 212     Fields:    Translation:Animals
    69. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998 May 01; 93(3):411-22. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. PMID: 9590175.
      View in: PubMed   Mentions: 444     Fields:    Translation:AnimalsCells
    70. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol. 1998; 42(7):995-1002. Bergers G, Hanahan D, Coussens LM. PMID: 9853830.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    71. Life events, emotional eating and change in body mass index. Int J Obes. 1986; 10(1):29-35. Van Strien T, Rookus MA, Bergers GP, Frijters JE, Defares PB. PMID: 3710686.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    Gabriele's Networks
    Concepts (326)
    Derived automatically from this person's publications.
    Co-Authors (32)
    People in Profiles who have published with this person.
    Similar People (57)
    People who share similar concepts with this person.
    Same Department
    Search Department